FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809428131> ?p ?o ?g. }

• W2809428131 endingPage "3096" @default.
• W2809428131 startingPage "3083" @default.
• W2809428131 abstract "Because of the rarity of neuroblastoma and poor survival until the 1990s, information on late effects in neuroblastoma survivors is sparse. We comprehensively reviewed the long‐term risk for somatic disease in neuroblastoma survivors. We identified 721 5‐year survivors of neuroblastoma in Nordic population‐based cancer registries and identified late effects in national hospital registries covering the period 1977–2012. Detailed treatment information was available for 46% of the survivors. The disease‐specific rates of hospitalization of survivors and of 152,231 randomly selected population comparisons were used to calculate standardized hospitalization rate ratios (SHRRs) and absolute excess risks (AERs). During 5,500 person‐years of follow‐up, 501 5‐year survivors had a first hospital contact yielding a SHRR of 2.3 (95% CI 2.1–2.6) and a corresponding AER of 52 (95% CI 44–60) per 1,000 person‐years. The highest relative risks were for diseases of blood and blood‐forming organs (SHRR 3.8; 95% CI 2.7–5.4), endocrine diseases (3.6 [3.1–4.2]), circulatory system diseases (3.1 [2.5–3.8]), and diseases of the nervous system (3.0 [2.6–3.3]). Approximately 60% of the excess new hospitalizations of survivors were for diseases of the nervous system, urinary system, endocrine system, and bone and soft tissue. The relative risks and AERs were highest for the survivors most intensively treated. Survivors of neuroblastoma have a highly increased long‐term risk for somatic late effects in all the main disease groups as compared to background levels. Our results are useful for counseling survivors and should contribute to improving health care planning in post‐therapy clinics." @default.
• W2809428131 created "2018-06-29" @default.
• W2809428131 creator A5015254988 @default.
• W2809428131 creator A5024021625 @default.
• W2809428131 creator A5030068105 @default.
• W2809428131 creator A5042104051 @default.
• W2809428131 creator A5042590591 @default.
• W2809428131 creator A5054216397 @default.
• W2809428131 creator A5056469678 @default.
• W2809428131 creator A5059586220 @default.
• W2809428131 creator A5072941760 @default.
• W2809428131 creator A5073788325 @default.
• W2809428131 creator A5075840216 @default.
• W2809428131 creator A5082007290 @default.
• W2809428131 creator A5086006915 @default.
• W2809428131 date "2018-10-16" @default.
• W2809428131 modified "2023-10-15" @default.
• W2809428131 title "Somatic late effects in 5‐year survivors of neuroblastoma: a population‐based cohort study within the Adult Life after Childhood Cancer in Scandinavia study" @default.
• W2809428131 cites W1545856126 @default.
• W2809428131 cites W1557414136 @default.
• W2809428131 cites W1984994518 @default.
• W2809428131 cites W1991016920 @default.
• W2809428131 cites W1998233750 @default.
• W2809428131 cites W2000308064 @default.
• W2809428131 cites W2015758016 @default.
• W2809428131 cites W2031613039 @default.
• W2809428131 cites W2032959114 @default.
• W2809428131 cites W2050141946 @default.
• W2809428131 cites W2072139071 @default.
• W2809428131 cites W2073654110 @default.
• W2809428131 cites W2083500054 @default.
• W2809428131 cites W2090114692 @default.
• W2809428131 cites W2111733282 @default.
• W2809428131 cites W2112309180 @default.
• W2809428131 cites W2121411489 @default.
• W2809428131 cites W2126177906 @default.
• W2809428131 cites W2133185906 @default.
• W2809428131 cites W2154117702 @default.
• W2809428131 cites W2155353212 @default.
• W2809428131 cites W2155899045 @default.
• W2809428131 cites W2159632692 @default.
• W2809428131 cites W2162757355 @default.
• W2809428131 cites W2206624148 @default.
• W2809428131 cites W2542452849 @default.
• W2809428131 cites W2570424533 @default.
• W2809428131 cites W4211031423 @default.
• W2809428131 doi "https://doi.org/10.1002/ijc.31631" @default.
• W2809428131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29926896" @default.
• W2809428131 hasPublicationYear "2018" @default.
• W2809428131 type Work @default.
• W2809428131 sameAs 2809428131 @default.
• W2809428131 citedByCount "13" @default.
• W2809428131 countsByYear W28094281312019 @default.
• W2809428131 countsByYear W28094281312020 @default.
• W2809428131 countsByYear W28094281312021 @default.
• W2809428131 countsByYear W28094281312022 @default.
• W2809428131 countsByYear W28094281312023 @default.
• W2809428131 crossrefType "journal-article" @default.
• W2809428131 hasAuthorship W2809428131A5015254988 @default.
• W2809428131 hasAuthorship W2809428131A5024021625 @default.
• W2809428131 hasAuthorship W2809428131A5030068105 @default.
• W2809428131 hasAuthorship W2809428131A5042104051 @default.
• W2809428131 hasAuthorship W2809428131A5042590591 @default.
• W2809428131 hasAuthorship W2809428131A5054216397 @default.
• W2809428131 hasAuthorship W2809428131A5056469678 @default.
• W2809428131 hasAuthorship W2809428131A5059586220 @default.
• W2809428131 hasAuthorship W2809428131A5072941760 @default.
• W2809428131 hasAuthorship W2809428131A5073788325 @default.
• W2809428131 hasAuthorship W2809428131A5075840216 @default.
• W2809428131 hasAuthorship W2809428131A5082007290 @default.
• W2809428131 hasAuthorship W2809428131A5086006915 @default.
• W2809428131 hasBestOaLocation W28094281311 @default.
• W2809428131 hasConcept C121608353 @default.
• W2809428131 hasConcept C126322002 @default.
• W2809428131 hasConcept C187212893 @default.
• W2809428131 hasConcept C201903717 @default.
• W2809428131 hasConcept C2776715637 @default.
• W2809428131 hasConcept C2778527826 @default.
• W2809428131 hasConcept C2779134260 @default.
• W2809428131 hasConcept C2780558122 @default.
• W2809428131 hasConcept C2908647359 @default.
• W2809428131 hasConcept C46699223 @default.
• W2809428131 hasConcept C54355233 @default.
• W2809428131 hasConcept C71315377 @default.
• W2809428131 hasConcept C71924100 @default.
• W2809428131 hasConcept C72563966 @default.
• W2809428131 hasConcept C81885089 @default.
• W2809428131 hasConcept C86803240 @default.
• W2809428131 hasConcept C99454951 @default.
• W2809428131 hasConceptScore W2809428131C121608353 @default.
• W2809428131 hasConceptScore W2809428131C126322002 @default.
• W2809428131 hasConceptScore W2809428131C187212893 @default.
• W2809428131 hasConceptScore W2809428131C201903717 @default.
• W2809428131 hasConceptScore W2809428131C2776715637 @default.
• W2809428131 hasConceptScore W2809428131C2778527826 @default.
• W2809428131 hasConceptScore W2809428131C2779134260 @default.
• W2809428131 hasConceptScore W2809428131C2780558122 @default.
• W2809428131 hasConceptScore W2809428131C2908647359 @default.

• next